Taiwan has ramped up production and imports of the main drug used to treat mycoplasma pneumoniae in children, amid a surge in cases of the respiratory illness reported in China in recent weeks, the Taiwan Food and Drug Administration (TFDA) said Wednesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Detention of 2 DPP ex-staffers in China espionage case extended
04/17/2025 09:59 PM - Politics
Ko Wen-je says he was improperly interrogated, calls for video release
04/17/2025 07:32 PM - Business
TSMC denies rumors about joint venture with Intel
04/17/2025 07:07 PM - Society
Taiwan headline news
04/17/2025 06:25 PM - Politics
Lai calls for more trade cooperation with NZ amid global challenges
04/17/2025 06:17 PM